EP3529359

TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.10.2017
  • EP published:
    13.12.2023
  • EP application number:
    17861792.4
  • Max expiry date:
    17.10.2037
  • Title in English:
    TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY
  • Language of the patent:
    English

Timeline

Today
18.10.2017EP application
13.12.2023EP Publication

Owner

  • Name:
    Regents of the University of Minnesota
  • Address:
    600 McNamara Alumni Center 200 Oak Street S.E., Minneapolis, MN 55455-2020, US
  • Name:
    Intima Bioscience, Inc.
  • Address:
    3 Columbus Circle, New York, New York 10019, US
  • Name:
    The United States of America, as represented by the Secretary, Department of Health and Human Services
  • Address:
    Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, US

Inventor

  • Name:
    MORIARITY, Branden
  • Address:
    Shoreview MN 55126-8516, US
  • Name:
    WEBBER, Beau
  • Address:
    Coon Rapids Minnesota 55448, US
  • Name:
    CHOUDHRY, Modassir
  • Address:
    New York New York 10019, US
  • Name:
    ROSENBERG, Steven A.
  • Address:
    Potomac Maryland 20854, US
  • Name:
    PALMER, Douglas C.
  • Address:
    N. Bethesda MD 20852, US
  • Name:
    RESTIFO, Nicholas P.
  • Address:
    Chevy Chase Maryland 20815, US

Priority

  • Number:
    201662409651 P
  • Date:
    18.10.2016
  • Country:
    US
  • Number:
    201762452244 P
  • Date:
    30.1.2017
  • Country:
    US

Classification

  • Categories:
    A61K 35/17, A61P 35/02, A61P 35/00, A61P 31/12, C07K 14/715, C07K 14/705, C07K 14/47, C12N 9/22, C12N 15/113, A61P 31/00

Upload documents